Research infrastructure services to enable R&I addressing main challenges and EU priorities related to the health domain
HORIZON-INFRA-2025-01-SERV-01
Funding Amount
Amount not specified
Deadline
18/09/2025
Eligible Organization Types
Non-profit, Private Business, Research Institution, Public Institution
Trusted by
What is the Research infrastructure services to enable R&I addressing main challenges and EU priorities related to the health domain Call?
Grant Description
This call supports trans-national and virtual access to existing European research infrastructures in the health domain. Funded activities include user access provision, training, technical support, service customisation and harmonisation, and short-term development of new or improved services. The objective is to enhance society’s evidence-based problem-solving capacity and policy support in one of three areas: epidemic preparedness medical countermeasures, paediatric clinical research, or link...
Required Results for Successful Funding
Expected Outcomes
For all areas: Provision of innovative, customized and efficient research infrastructure services that enhance society’s long-term problem-solving capacity and evidence-based policymaking in the health domain.
Area 1 (Epidemic response):
• Excellent research and innovation to identify, characterize and mitigate effects of existing and emerging pathogens
• Comprehensive, up-to-date catalogue of infrastructure services for infectious disease epidemics
• Increased knowledge and development of intervention tools (diagnostics, therapies, vaccines, vector control)
• Availability of research data for reuse on common platforms and registries under FAIR and GDPR
• Challenge-driven integration and alignment with the future Pandemic Preparedness Partnership, EU Reference Laboratories and DURABLE network
• A long-term sustainability concept for the epidemic research infrastructure network
Area 2 (Paediatric clinical research):
• Advancement of paediatric medicines and diagnostic/therapeutic approaches to market and clinical use
• Accelerated availability of solutions for paediatric patients
• Wider access to rationally designed services across Europe, supporting competitiveness of industry and biotech SMEs
• Joint efforts of infrastructures and paediatric competence networks within the EU regulatory framework
• Availability of innovative tools for paediatric trials, reuse of population/historical data and enhanced data sharing across care levels and regions
Area 3 (Environment-health research):
• Improved risk assessment tools and data to anticipate and mitigate negative environmental impacts on human health
• Evidence to inform policymaking and public health bodies on environmental health risk management
• Wider access to specialized services underpinning competitiveness of industry and SMEs in environmental risk assessment
• Links with research on exposure to living organisms under the One-Health concept
Area 1 (Epidemic response):
• Excellent research and innovation to identify, characterize and mitigate effects of existing and emerging pathogens
• Comprehensive, up-to-date catalogue of infrastructure services for infectious disease epidemics
• Increased knowledge and development of intervention tools (diagnostics, therapies, vaccines, vector control)
• Availability of research data for reuse on common platforms and registries under FAIR and GDPR
• Challenge-driven integration and alignment with the future Pandemic Preparedness Partnership, EU Reference Laboratories and DURABLE network
• A long-term sustainability concept for the epidemic research infrastructure network
Area 2 (Paediatric clinical research):
• Advancement of paediatric medicines and diagnostic/therapeutic approaches to market and clinical use
• Accelerated availability of solutions for paediatric patients
• Wider access to rationally designed services across Europe, supporting competitiveness of industry and biotech SMEs
• Joint efforts of infrastructures and paediatric competence networks within the EU regulatory framework
• Availability of innovative tools for paediatric trials, reuse of population/historical data and enhanced data sharing across care levels and regions
Area 3 (Environment-health research):
• Improved risk assessment tools and data to anticipate and mitigate negative environmental impacts on human health
• Evidence to inform policymaking and public health bodies on environmental health risk management
• Wider access to specialized services underpinning competitiveness of industry and SMEs in environmental risk assessment
• Links with research on exposure to living organisms under the One-Health concept
Funded areas
Scope Requirements
Proposals must:
• Explicitly address one of three areas (epidemic countermeasures, paediatric clinical research, or environment-health research) and state which area is targeted
• Provide trans-national (on-site or remote) and/or virtual access to existing services offered by research infrastructures of European interest
• Include ad hoc users’ training, scientific and technical support, and dedicated training courses for data stewardship skills
• Facilitate and integrate access procedures and further develop remote/virtual service provision
• Improve, customize and harmonize infrastructure services, supporting only short-term R&D for service enhancements
• Ensure long-term sustainability of services; justify any mid-term (2–3 year) service developments
• Adhere to the European Charter for Access to Research Infrastructures, FAIR principles and GDPR provisions
• Address data management, ethics, interoperability and EOSC integration where relevant
• Involve a necessary interdisciplinary set of research infrastructures of European interest, and include at least one ESFRI Landmark or ERIC as beneficiary (or hosting entity with supporting declaration)
• Optionally involve complementary third-country infrastructures under eligibility rules
• Include an outreach and engagement plan to advertise services to widening countries, industries and SMEs
• Specify the list of services/installations opened for access and the units of access available per user
• Explicitly address one of three areas (epidemic countermeasures, paediatric clinical research, or environment-health research) and state which area is targeted
• Provide trans-national (on-site or remote) and/or virtual access to existing services offered by research infrastructures of European interest
• Include ad hoc users’ training, scientific and technical support, and dedicated training courses for data stewardship skills
• Facilitate and integrate access procedures and further develop remote/virtual service provision
• Improve, customize and harmonize infrastructure services, supporting only short-term R&D for service enhancements
• Ensure long-term sustainability of services; justify any mid-term (2–3 year) service developments
• Adhere to the European Charter for Access to Research Infrastructures, FAIR principles and GDPR provisions
• Address data management, ethics, interoperability and EOSC integration where relevant
• Involve a necessary interdisciplinary set of research infrastructures of European interest, and include at least one ESFRI Landmark or ERIC as beneficiary (or hosting entity with supporting declaration)
• Optionally involve complementary third-country infrastructures under eligibility rules
• Include an outreach and engagement plan to advertise services to widening countries, industries and SMEs
• Specify the list of services/installations opened for access and the units of access available per user
Additional Conditions for Applicants
Special Conditions
- Proposals must include access provision activities; no separate exploitation/dissemination plan is required
• Maximum 100 pages for the application (Part B of the Application Form)
• Single-stage submission; deadline 18 September 2025, 17:00 Brussels time
• Eligible third-country entities from Australia, Brazil, Canada, Chile, India, Japan, Mexico, New Zealand, Republic of Korea, Singapore, Switzerland and the USA may receive Union funding if they provide access
• The Joint Research Centre (JRC) may participate in funded consortia
• Eligible costs for access provision are reimbursed as unit costs as per the Model Grant Agreement
• Evaluation will ensure a balanced portfolio across the three areas; additional excellence sub-criteria will assess quality of access activities and service development
• Compliance with the “Specific features for Research Infrastructures” section of the Work Programme will be assessed during evaluation
• No support for longer-term R&D of new instrumentation, tools, methods or advanced digital solutions
• Maximum 100 pages for the application (Part B of the Application Form)
• Single-stage submission; deadline 18 September 2025, 17:00 Brussels time
• Eligible third-country entities from Australia, Brazil, Canada, Chile, India, Japan, Mexico, New Zealand, Republic of Korea, Singapore, Switzerland and the USA may receive Union funding if they provide access
• The Joint Research Centre (JRC) may participate in funded consortia
• Eligible costs for access provision are reimbursed as unit costs as per the Model Grant Agreement
• Evaluation will ensure a balanced portfolio across the three areas; additional excellence sub-criteria will assess quality of access activities and service development
• Compliance with the “Specific features for Research Infrastructures” section of the Work Programme will be assessed during evaluation
• No support for longer-term R&D of new instrumentation, tools, methods or advanced digital solutions
Important dates
Open from: 06/05/2025
Deadline:18/09/2025
Application period has ended
Win your grant with Cogrant
How cogrant works
Smart Funding Fit Check
Instantly know if your project fits call criteria. Our system highlights strengths, gaps, and risks, so you only apply when your chances are real.
Intelligent Research Engine
Our research engine digs deeper than any founder could alone. It pulls data about your company, your market, and even your competitors - giving your proposal an edge backed by facts, not fluff.
Full Proposal Development
Our system builds your entire proposal from start to finish, ensuring every section is complete, coherent, and crafted to the highest quality. You focus on your vision — we deliver the winning document.
Expert Review
Our experts run a complete review before delivery, ensuring your draft proposal is accurate, well-structured, and polished. You’ll receive a high-quality draft that’s ready for your final touches before submission.
Our Numbers
Results that speak for themselves
70+
proposals prepared
€36.7M
total funding secured for clients
65%
win rate in highly competitive calls